Correlation of nutritional support and immunonutritional indicators with prognosis and survival in esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy

营养支持和免疫营养指标与接受同步放化疗的食管鳞状细胞癌患者的预后和生存率的相关性

阅读:2

Abstract

BACKGROUND AND AIMS: Esophageal squamous cell carcinoma (ESCC) is commonly associated with high rates of malnutrition, adversely affecting patient outcomes. This study aims to assess the impact of nutritional support combined with concurrent chemoradiotherapy (CCRT) on survival and prognosis in ESCC patients, utilizing prognostic models based on five key immunonutritional indicators. METHODS: In this retrospective study, we reviewed the medical records of 200 esophageal squamous cell carcinoma patients who were treated between January 2017 and June 2022. Patients were categorized into two groups based on their treatment records: one group received nutritional support in addition to standard CCRT, and the other received only CCRT. We retrospectively analyzed survival outcomes using Kaplan-Meier curves and log-rank tests, and identified independent prognostic factors through Cox proportional hazards models. The study further assessed five specific immunonutritional indicators to develop and validate predictive nomogram models. The effectiveness of these models was evaluated using receiver operating characteristic (ROC) curve analysis to determine their predictive accuracy for patient outcomes. RESULTS: Nutritional support improved overall survival (OS) and progression-free survival (PFS) compared to the non-nutritional group. Patients in the nutritional group showed better biochemical markers and quality of life with fewer treatment-related complications. The nomogram models based on the immunonutritional indicators demonstrated strong predictive accuracy for both OS and PFS, with LMY and PAR showing the highest prognostic power. CONCLUSIONS: Integrating nutritional support into the treatment plan for ESCC patients undergoing CCRT enhances may enhance treatment tolerance, reduce toxicity, and indirectly contribute to improved survival rates, quality of life, and fewer complications. The five immunonutritional indicators provide robust predictive capabilities for patient outcomes, supporting the use of personalized nutritional interventions and nomogram models in clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。